Anemia in Patients with Heart Failure: Current State of the Problem

The article reports the modern tactics of treating patients with chronic heart failure and concomitant anemia. The results of the most important randomized clinical trials that are the basis for developing approaches to the treatment of anemia in such cases are discussed. Attention is also paid to unresolved problems in the treatment of anemia in patients with heart failure. The data on the intravenous administration of iron preparations as the most effective approach to the treatment of anemia in patients with heart failure in the presence of iron defciency are given. The main provisions of modern clinical guidelines on the management of patients with heart failure and anemia are considered.

• Publication year

  2019

• Venue

  Russian Sklifosovsky Journal "Emergency Medical Care"

• Publication date

  2019-04-23

• Fields of study

  Not labeled

• Identifiers
  DOI 10.23934/2223-9022-2019-8-1-68-73
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Anaemia in heart failure: still relevant?

  2020cited by this paper
• Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron‐deficient heart failure patients: an individual patient data meta‐analysis

  2018cited by this paper
• The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure.

  2016cited by this paper
• Erythropoietin in the General Population: Reference Ranges and Clinical, Biochemical and Genetic Correlates

  2015cited by this paper
• Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease

  2015cited by this paper
• Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†

  2014cited by this paper
• The additive burden of iron deficiency in the cardiorenal–anaemia axis: scope of a problem and its consequences

  2014cited by this paper
• Iron deficiency in chronic heart failure: an international pooled analysis.

  2013cited by this paper
• Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• Baseline anemia is not a predictor of all-cause mortality in outpatients with advanced heart failure or severe renal dysfunction. Results from the Norwegian Heart Failure Registry.

  2012cited by this paper
• Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival.

  2011cited by this paper
• Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches

  2011cited by this paper
• Characteristics and outcomes among heart failure patients with anemia and renal insufficiency with and without blood transfusions (public discharge data from California 2000-2006).

  2011cited by this paper
• Bone marrow dysfunction in chronic heart failure patients

  2010cited by this paper
• Blood transfusion for acute decompensated heart failure--friend or foe?

  2009cited by this paper
• Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure.

  2008cited by this paper
• Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume.

  2008cited by this paper
• Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients.

  2008cited by this paper
• Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.

  2008cited by this paper
• Anemia and mortality in heart failure patients a systematic review and meta-analysis.

  2008cited by this paper
• Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.

  2007cited by this paper
• Etiology of anemia in patients with advanced heart failure.

  2006cited by this paper
• The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.

  2006cited by this paper
• Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction.

  2005cited by this paper
• Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.

  2004cited by this paper
• Human cardiovascular and metabolic response to acute, severe isovolemic anemia.

  1998cited by this paper
• Clinical research

  1995cited by this paper

• Euvolemia as a criterion of diuretic therapy efficacy in chronic heart failure: Literature review

  2020cites this paper